Comparison of silodosin to tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis (original) (raw)

Abstract

sparkles

AI

This study aimed at comparing the success rates of silodosin to tamsulosin for the management of ureteral stones through a systematic review and meta-analysis. A systematic review was conducted on major databases, culminating in the inclusion of three randomized controlled trials with 407 patients. Results demonstrated silodosin yielding significantly higher stone expulsion rates and faster expulsion times compared to tamsulosin, indicating a potential advantage of silodosin in medical expulsive therapy for ureteral stones.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (23)

  1. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK (2006) Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368(9542):1171- 1179. doi:10.1016/s0140-6736(06)69474-9
  2. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56(3):455-471. doi:10.1016/j. eururo.2009.06.012
  3. Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2014) Guidelines on urolithiasis. In: EAU guidelines, edition presented at the 29th EAU annual congress, Stockholm
  4. Parsons JK, Hergan LA, Sakamoto K, Lakin C (2007) Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol 177(3):983-987. doi:10.1016/j.juro.2006.10.023 (discussion 987)
  5. Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, Bozkirli I (2004) Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 64(6):1111-1115. doi:10.1016/j.urology.2004.07.020
  6. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol Off J Jpn Urol Assoc 14(8):749-753. doi:10.1111/j.1442-2042.2007.01812.x
  7. Sasaki S, Tomiyama Y, Kobayashi S, Kojima Y, Kubota Y, Kohri K (2011) Characterization of alpha1-adrenoceptor sub- types mediating contraction in human isolated ureters. Urology 77(3):762 e713-767. doi:10.1016/j.urology.2010.09.034
  8. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different alpha1-adr- energic blockers for distal ureteral stones. J Urol 173(6):2010- 2012. doi:10.1097/01.ju.0000158453.60029.0a
  9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Con- trol Clin Trials 17(1):1-12
  10. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, New York
  11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ Clin Res Ed 327(7414):557-560. doi:10.1136/bmj.327.7414.557
  13. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot- based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455-463
  14. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ Clin Res Ed 315(7109):629-634
  15. Dell'Atti L (2014) Silodosin versus Tamsulosin as medical expulsive therapy for distal ureteral stones: a prospective rand- omized study. Urologia. doi:10.5301/uro.5000083
  16. Kumar S, Jayant K, Agrawal MM, Singh SK, Agrawal S, Parmar KM (2015) Role of tamsulosin, tadalafil, and silodosin as the medical expulsive therapy in lower ureteric stone: a randomized trial (a pilot study). Urology 85(1):59-63
  17. Gupta S, Lodh B, Kaku Singh A, Somarendra K, Sholay Meitei K, Rajendra Singh S (2013) Comparing the efficacy of tamsu- losin and silodosin in the medical expulsion therapy for ure- teral calculi. J Clin Diagn Res 7(8):1672-1674. doi:10.7860/ JCDR/2013/6141.3241
  18. Rossi M, Roumeguere T (2010) Silodosin in the treatment of benign prostatic hyperplasia. Drug Design Dev Ther 4:291-297. doi:10.2147/dddt.s10428
  19. Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez Fernandez E (2011) Silodosin therapy for lower urinary tract symptoms in men with suspected benign pro- static hyperplasia: results of an international, randomized, double-blind, placebo-and active-controlled clinical trial per- formed in Europe. Eur Urol 59(3):342-352. doi:10.1016/j. eururo.2010.10.046
  20. Itoh Y, Okada A, Yasui T, Ando R, Tozawa K, Sasaki S, Kohri K (2013) Administration of the selective alpha 1A-adrenoceptor antagonist silodosin facilitates expulsion of size 5-10 mm dis- tal ureteral stones, as compared to control. Int Urol Nephrol 45(3):675-678
  21. Imperatore V, Fusco F, Creta M, Di Meo S, Buonopane R, Longo N, Imbimbo C, Mirone V (2014) Medical expulsive therapy for distal ureteric stones: tamsulosin versus silodosin. Archivio Italiano di Urologia e Andrologia 86(2):103-107
  22. Rathi S, Agarwal A, Patnaik P, Shaw D, Trivedi S, Dwivedi US (2014) Evaluation of medical expulsive therapy for distal ure- teral stone: a prospective randomized controlled study to com- pare silodosin versus tamsulosin. Indian J Urol 30:S83
  23. Huang W, Xue P, Zong H, Zhang Y (2016) Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral cal- culi: a systematic review and meta-analysis. Br J Clin Pharmacol 81(1):13-22. doi:10.1111/bcp.12737